Literature DB >> 33428056

Association of dietary diversity score (DDS) and migraine headache severity among women.

Faezeh Khorsha1, Atieh Mirzababaei1,2, Mansoureh Togha3,4, Khadijeh Mirzaei5.   

Abstract

BACKGROUND AND OBJECTIVES: Migraine is an episodic disorder that is characterized by unilateral headache lasting 4-72 h along with certain associated features. Modifying dietary habits have been considered an appropriate therapeutic approach in these patients. This study was designed to examine the association between dietary diversity score (DDS) and severity, frequency, and duration of migraine attacks. METHODS AND MATERIALS: The present study was conducted using a cross-sectional design on 256 women 18-50 years old referred to neurology clinics for the first time. After the diagnosis of migraine by a neurologist, the data related to anthropometric measures and dietary intake (147-item semi-quantitative food frequency questionnaire) were collected. To assess migraine severity, the migraine disability assessment questionnaire (MIDAS), visual analog scale (VAS), and a 30-day headache diary were used. Multinomial logistic regression was used to evaluate the association between DDS and migraine severity. The age, physical activity, BMI, and job were considered confounding variables in regression model. Data were analyzed using SPSS software and P values < 0.05 considered statistically significant.
RESULTS: Totally, 256 subjects participated in the present study with mean age, height, weight, and BMI of 34.28 ± 7.88 years, 161.78 ± 5.18 cm, 69.25 ± 13.06 kg, and 26.46 ± 4.89 kg/m2, respectively. Subjects with higher DDS had a lower waist circumference (P = 0.01). There was no association between DDS and other anthropometric measures and demographic characteristics (P > 0.05). In the crude model of logistic regression, participants with lower DDS had higher odds of more pain severity (OR = 2.30; 95% CI = 1.28, 4.12; P = 0.005), migraine disability (OR = 2.66; 95% CI = 1.51, 4.69; P = 0.001), and headache duration (OR = 2.32; CI = 1.22, 4.40; P = 0.01) compared to reference group. No association was found between headache frequency and DDS. Adjusting for the effect of confounding variables did not change the significant association.
CONCLUSION: DDS was inversely associated with migraine disability, pain severity, and headache frequency. Additional studies are needed to replicate these findings and to explore mechanisms that mediate the association between DDS and migraine attacks.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Dietary diversity; Disability; Headache; Migraine; Visual analog scale

Year:  2021        PMID: 33428056     DOI: 10.1007/s10072-020-04982-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  32 in total

1.  Prevalence and characteristics of migraine in women of reproductive age in Istanbul, Turkey: a population based survey.

Authors:  Ulkü Türk Börü; Abdulkadir Koçer; Arda Lüleci; Haydar Sur; Hava Tutkan; Hakki Atli
Journal:  Tohoku J Exp Med       Date:  2005-05       Impact factor: 1.848

Review 2.  New therapeutic approaches for the prevention and treatment of migraine.

Authors:  Hans-Christoph Diener; Andrew Charles; Peter J Goadsby; Dagny Holle
Journal:  Lancet Neurol       Date:  2015-10       Impact factor: 44.182

Review 3.  Prophylaxis of migraine headaches with riboflavin: A systematic review.

Authors:  D F Thompson; H S Saluja
Journal:  J Clin Pharm Ther       Date:  2017-05-08       Impact factor: 2.512

Review 4.  Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Authors:  S D Silberstein; S Holland; F Freitag; D W Dodick; C Argoff; E Ashman
Journal:  Neurology       Date:  2012-04-24       Impact factor: 9.910

Review 5.  The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.

Authors:  Michael J Marmura; Stephen D Silberstein; Todd J Schwedt
Journal:  Headache       Date:  2015-01       Impact factor: 5.887

Review 6.  Diet and Headache: Part 1.

Authors:  Vincent T Martin; Brinder Vij
Journal:  Headache       Date:  2016-10       Impact factor: 5.887

Review 7.  Foods and supplements in the management of migraine headaches.

Authors:  Christina Sun-Edelstein; Alexander Mauskop
Journal:  Clin J Pain       Date:  2009-06       Impact factor: 3.442

8.  The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010.

Authors:  Harvey A Whiteford; Alize J Ferrari; Louisa Degenhardt; Valery Feigin; Theo Vos
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 9.  Migraine pathogenesis and state of pharmacological treatment options.

Authors:  Till Sprenger; Peter J Goadsby
Journal:  BMC Med       Date:  2009-11-16       Impact factor: 8.775

Review 10.  An Update: Pathophysiology of Migraine.

Authors:  Peter J Goadsby; Philip R Holland
Journal:  Neurol Clin       Date:  2019-11       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.